212 related articles for article (PubMed ID: 31979093)
21. Long noncoding RNA HCP5 contributes to cisplatin resistance in human triple-negative breast cancer via regulation of PTEN expression.
Wu J; Chen H; Ye M; Wang B; Zhang Y; Sheng J; Meng T; Chen H
Biomed Pharmacother; 2019 Jul; 115():108869. PubMed ID: 31028999
[TBL] [Abstract][Full Text] [Related]
22. Epigenetic Activation of TWIST1 by MTDH Promotes Cancer Stem-like Cell Traits in Breast Cancer.
Liang Y; Hu J; Li J; Liu Y; Yu J; Zhuang X; Mu L; Kong X; Hong D; Yang Q; Hu G
Cancer Res; 2015 Sep; 75(17):3672-80. PubMed ID: 26141861
[TBL] [Abstract][Full Text] [Related]
23. MiR-137 Suppresses Triple-Negative Breast Cancer Stemness and Tumorigenesis by Perturbing BCL11A-DNMT1 Interaction.
Chen F; Luo N; Hu Y; Li X; Zhang K
Cell Physiol Biochem; 2018; 47(5):2147-2158. PubMed ID: 29975921
[TBL] [Abstract][Full Text] [Related]
24. Schlafen12 Reduces the Aggressiveness of Triple Negative Breast Cancer through Post-Transcriptional Regulation of ZEB1 That Drives Stem Cell Differentiation.
Al-Marsoummi S; Vomhof-DeKrey E; Basson MD
Cell Physiol Biochem; 2019; 53(6):999-1014. PubMed ID: 31838790
[TBL] [Abstract][Full Text] [Related]
25. MELK as a potential target to control cell proliferation in triple-negative breast cancer MDA-MB-231 cells.
Li G; Yang M; Zuo L; Wang MX
Oncol Lett; 2018 Jun; 15(6):9934-9940. PubMed ID: 29805690
[TBL] [Abstract][Full Text] [Related]
26. Jagged2 promotes cancer stem cell properties of triple negative breast cancer cells and paclitaxel resistance via regulating microRNA-200.
Li CY; Miao KL; Chen Y; Liu LY; Zhao GB; Lin MH; Jiang C
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):6008-6014. PubMed ID: 30280784
[TBL] [Abstract][Full Text] [Related]
27. Metadherin enhances the invasiveness of breast cancer cells by inducing epithelial to mesenchymal transition.
Li X; Kong X; Huo Q; Guo H; Yan S; Yuan C; Moran MS; Shao C; Yang Q
Cancer Sci; 2011 Jun; 102(6):1151-7. PubMed ID: 21371176
[TBL] [Abstract][Full Text] [Related]
28. Phenethyl isothiocyanate suppresses cancer stem cell properties in vitro and in a xenograft model.
Yun JH; Kim KA; Yoo G; Kim SY; Shin JM; Kim JH; Jung SH; Kim J; Nho CW
Phytomedicine; 2017 Jul; 30():42-49. PubMed ID: 28545668
[TBL] [Abstract][Full Text] [Related]
29. Phenethyl isothiocyanate inhibits colorectal cancer stem cells by suppressing Wnt/β-catenin pathway.
Chen Y; Li Y; Wang XQ; Meng Y; Zhang Q; Zhu JY; Chen JQ; Cao WS; Wang XQ; Xie CF; Li XT; Geng SS; Wu JS; Zhong CY; Han HY
Phytother Res; 2018 Dec; 32(12):2447-2455. PubMed ID: 30159926
[TBL] [Abstract][Full Text] [Related]
30. Effect of apigenin on whole transcriptome profile of TNFα-activated MDA-MB-468 triple negative breast cancer cells.
Bauer D; Mazzio E; Hilliard A; Oriaku ET; Soliman KFA
Oncol Lett; 2020 Mar; 19(3):2123-2132. PubMed ID: 32194710
[TBL] [Abstract][Full Text] [Related]
31. MTDH mediates trastuzumab resistance in HER2 positive breast cancer by decreasing PTEN expression through an NFκB-dependent pathway.
Du C; Yi X; Liu W; Han T; Liu Z; Ding Z; Zheng Z; Piao Y; Yuan J; Han Y; Xie M; Xie X
BMC Cancer; 2014 Nov; 14():869. PubMed ID: 25417825
[TBL] [Abstract][Full Text] [Related]
32. Breast Cancer Stem-Like Cells Are Inhibited by Diosgenin, a Steroidal Saponin, by the Attenuation of the Wnt β-Catenin Signaling via the Wnt Antagonist Secreted Frizzled Related Protein-4.
Bhuvanalakshmi G; Basappa ; Rangappa KS; Dharmarajan A; Sethi G; Kumar AP; Warrier S
Front Pharmacol; 2017; 8():124. PubMed ID: 28373842
[No Abstract] [Full Text] [Related]
33. Regulation of Cellular and Cancer Stem Cell-Related Putative Gene Expression of Parental and CD44
Koh MZ; Ho WY; Yeap SK; Ali NM; Boo L; Alitheen NB
Pharmaceuticals (Basel); 2021 Apr; 14(5):. PubMed ID: 33919109
[TBL] [Abstract][Full Text] [Related]
34. Metabolic and lipidomic characterization of radioresistant MDA-MB-231 human breast cancer cells to investigate potential therapeutic targets.
Lee H; To NB; Kim M; Nguyen YT; Cho SK; Choi HK
J Pharm Biomed Anal; 2022 Jan; 208():114449. PubMed ID: 34749107
[TBL] [Abstract][Full Text] [Related]
35. Phenethyl isothiocyanate, by virtue of its antioxidant activity, inhibits invasiveness and metastatic potential of breast cancer cells: HIF-1α as a putative target.
Sarkar R; Mukherjee S; Biswas J; Roy M
Free Radic Res; 2016; 50(1):84-100. PubMed ID: 26480821
[TBL] [Abstract][Full Text] [Related]
36. The Milk Protein Alpha-Casein Suppresses Triple Negative Breast Cancer Stem Cell Activity Via STAT and HIF-1alpha Signalling Pathways in Breast Cancer Cells and Fibroblasts.
Garner KEL; Hull NJ; Sims AH; Lamb R; Clarke RB
J Mammary Gland Biol Neoplasia; 2019 Sep; 24(3):245-256. PubMed ID: 31529195
[TBL] [Abstract][Full Text] [Related]
37. Downregulation of TMPRSS4 Enhances Triple-Negative Breast Cancer Cell Radiosensitivity Through Cell Cycle and Cell Apoptosis Process Impairment.
Assani G; Segbo J; Yu X; Yessoufou A; Xiong Y; Zhou F; Zhou Y
Asian Pac J Cancer Prev; 2019 Dec; 20(12):3679-3687. PubMed ID: 31870109
[TBL] [Abstract][Full Text] [Related]
38. GABARAPL1 acts as a potential marker and promotes tumor proliferation and metastasis in triple negative breast cancer.
Ran L; Hong T; Xiao X; Xie L; Zhou J; Wen G
Oncotarget; 2017 Sep; 8(43):74519-74526. PubMed ID: 29088804
[TBL] [Abstract][Full Text] [Related]
39. Metadherin promotes metastasis by supporting putative cancer stem cell properties and epithelial plasticity in pancreatic cancer.
Suzuki K; Takano S; Yoshitomi H; Nishino H; Kagawa S; Shimizu H; Furukawa K; Miyazaki M; Ohtsuka M
Oncotarget; 2017 Sep; 8(39):66098-66111. PubMed ID: 29029495
[TBL] [Abstract][Full Text] [Related]
40. Radiosensitization with combined use of olaparib and PI-103 in triple-negative breast cancer.
Jang NY; Kim DH; Cho BJ; Choi EJ; Lee JS; Wu HG; Chie EK; Kim IA
BMC Cancer; 2015 Mar; 15():89. PubMed ID: 25884663
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
